{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:17:19Z","timestamp":1747185439440,"version":"3.40.5"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The prothrombin time (PT) is the most requested test to investigate patients with congenital or acquired coagulopathies or to monitor oral anticoagulant therapy. However, thromboplastins can show markedly different responsiveness to the defects induced by vitamin K antagonist (VKA) therapy and are thus characterized by their ISI (International Sensitivity Index). INR results are optimal for patients under VKA but for patients screened for other reasons expressing PT results as ratio can be more appropriate. As it is very difficult to define the PT results reporting unit from the PT testing request, it would be ideal to use a thromboplastin with ISI\u00a0=\u00a01. The study aims to compare our reference PT reagent with two candidate thromboplastins with ISI close to 1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We compared 3 different thromplastins: two rabbit brain extracted based reagents (STA\u2010Neoplastine CI Plus, with ISI\u00a0=\u00a01.26, routinely used in our laboratory and STA\u2010NeoPTimal with ISI\u00a0=\u00a01.01) and a recombinant thromboplastin (STA\u2010Neoplastine R with ISI\u00a0=\u00a00.97). The comparison was done on 175 samples: 75 from individuals without coagulation defects and 100 from patients under VKA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>STA\u2010NeoPTimal and STA\u2010Neoplastine R well correlate to our reference, STA\u2010Neoplastine CI Plus: regression equations are y\u00a0=\u00a01.186x\u20100.1351, <jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>\u00a0=\u00a0.9454 and y\u00a0=\u00a01.1432x\u20100.1554, <jats:italic>r<\/jats:italic><jats:sup>2<\/jats:sup>\u00a0=\u00a0.9951, respectively. The lowest bias on INR results was obtained with STA\u2010NeoPTimal reagent (interval: \u22120.7\/+0.4).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We conclude that STA\u2010NeoPTimal can be used in the laboratory as it gives results comparable to those obtained with STA\u2010Neoplastine CI Plus. Besides, thanks to its ISI\u00a0=\u00a01, it guarantees reporting a PT ratio equal to INR which avoids errors.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijlh.13365","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T15:49:42Z","timestamp":1603036182000},"page":"311-317","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of STA\u2010NeoPTimal, an extraction thromboplastin reagent with ISI close to 1"],"prefix":"10.1111","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-4928","authenticated-orcid":false,"given":"Mariarosa","family":"Carta","sequence":"first","affiliation":[{"name":"AULSS 8 Berica Medicina di Laboratorio Vicenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bonente","sequence":"additional","affiliation":[{"name":"AULSS 9 Scaligera Laboratorio di Analisi chimico\u2010cliniche e Microbiologia San Bonifacio Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Teresa Comberlato","sequence":"additional","affiliation":[{"name":"AULSS 8 Berica Medicina di Laboratorio Vicenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Pellizzari","sequence":"additional","affiliation":[{"name":"AULSS 8 Berica Medicina di Laboratorio Vicenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Marotto","sequence":"additional","affiliation":[{"name":"AULSS 8 Berica Medicina di Laboratorio Vicenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Marzari","sequence":"additional","affiliation":[{"name":"AULSS 8 Berica Medicina di Laboratorio Vicenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9589-178X","authenticated-orcid":false,"given":"Davide","family":"Giavarina","sequence":"additional","affiliation":[{"name":"AULSS 8 Berica Medicina di Laboratorio Vicenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,10,18]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2825(2000)14:3<101::AID-JCLA4>3.0.CO;2-A"},{"key":"e_1_2_7_3_1","unstructured":"ShikdarS BhattacharyaPT.International Normalized Ratio (INR) Updated 2019 Mar 25. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing;2020Jan\u2010.https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507707\/. Accessed October 10 2020."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13611"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01848.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13879"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657371"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-0657"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.161364"},{"volume-title":"Measurement Procedure Comparison and Bias Estimation Using Patient Sample; Approved Guideline\u2010Third Edition. CLSI document EP09\u2010A3","year":"2013","author":"CLSI","key":"e_1_2_7_10_1"},{"volume-title":"One\u2010Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline\u2010Second Edition. CLSI document H47\u2010A2","year":"2008","author":"CLSI","key":"e_1_2_7_11_1"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000063575.17904.4E"},{"key":"e_1_2_7_13_1","first-page":"1265","article-title":"Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system","volume":"87","author":"Testa S","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_7_14_1","first-page":"1074","article-title":"Relationship between international normalized ratio values, vitamin k dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment","volume":"87","author":"D\u2019Angelo A","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13236"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.05.001"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07282-3"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03834.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21732"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00897.x"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.13365","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.13365","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.13365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T14:30:47Z","timestamp":1693578647000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.13365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,18]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/ijlh.13365"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.13365","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"type":"print","value":"1751-5521"},{"type":"electronic","value":"1751-553X"}],"subject":[],"published":{"date-parts":[[2020,10,18]]},"assertion":[{"value":"2020-07-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}